JPS5824434B2 - Method for producing piperidino-propanol derivatives - Google Patents

Method for producing piperidino-propanol derivatives

Info

Publication number
JPS5824434B2
JPS5824434B2 JP21590781A JP21590781A JPS5824434B2 JP S5824434 B2 JPS5824434 B2 JP S5824434B2 JP 21590781 A JP21590781 A JP 21590781A JP 21590781 A JP21590781 A JP 21590781A JP S5824434 B2 JPS5824434 B2 JP S5824434B2
Authority
JP
Japan
Prior art keywords
general formula
formula
autoclave
piperidino
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP21590781A
Other languages
Japanese (ja)
Other versions
JPS57188569A (en
Inventor
アンリ・パスドウエ
ジヨルジユ・ゴブロン
ロベール・ピポン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Funai Pharmaceutical Industries Ltd
Original Assignee
Funai Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Funai Pharmaceutical Industries Ltd filed Critical Funai Pharmaceutical Industries Ltd
Publication of JPS57188569A publication Critical patent/JPS57188569A/en
Publication of JPS5824434B2 publication Critical patent/JPS5824434B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)

Description

【発明の詳細な説明】 本発明は、一般式 (式中、Rはアルキル基例えばメチル基もしくはエチル
基、アリールアルキル基例えばベンジル基、またはアリ
ール基例えばフェニル基を示す)を有:するピペリジノ
−プロパノール誘導体およびその酸付加塩の新規な製造
方法を提供するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides piperidino- A novel method for producing propanol derivatives and acid addition salts thereof is provided.

上記一般式(I)で表わされる化合物は医薬、特に心臓
脈疾患の処置に有効な医薬として有用な物質である。
The compound represented by the above general formula (I) is a substance useful as a medicine, particularly as a medicine effective in treating heart disease.

本発明は上記一般式(I)で表わされる化合物の新規な
工業的製法を提供するものである。
The present invention provides a new industrial method for producing the compound represented by the above general formula (I).

本発明の方法により、一般式、 (式中、Rはアルキル基、アリールアルキル基またはア
リール基を示す)を有する置換ピリジンと一般式、 (式中、Xは・・ロゲン原子を示す)を有するp −ベ
ンジルオキシ−α−ハローグロピオフエノンとを反応せ
しめて式 (式中、Rは前述の定義を有し、そしてX○はハロゲン
イオンを示す)を有するアンモニウム塩を製造し、次い
でこれを水素添加触媒の存在下で水素添加することによ
り、前記一般式(I)で表わされるピペリジノーグロパ
ノール誘導体が効率よく得られる。
By the method of the present invention, a substituted pyridine having the general formula: (wherein R represents an alkyl group, an arylalkyl group or an aryl group) and a substituted pyridine having the general formula: (wherein, X represents a rogen atom) p -benzyloxy-α-halogropiofenone to produce an ammonium salt having the formula, where R has the above definition and X represents a halogen ion; By hydrogenating in the presence of a hydrogenation catalyst, the piperidinoglopanol derivative represented by the general formula (I) can be efficiently obtained.

一般式へで表わされる化合物は、一般式、(式中、Rは
前記の定義を有する)で表わされる置換ピリジンと一般
式 (式中、Xは)叩ゲン原子、特に臭素原子を示す〕ヲ有
スるp−ベンジルオキシ−α−ハロープロピオフェノン
とを反応させることによって得られるが、この反応は、
一般に、式(I[)で表わされる化合物および式曲で表
わされる化合物が可溶で、かつ一般式■の生成物が難溶
または不溶である希釈剤中で行なわれる。
The compound represented by the general formula is a substituted pyridine represented by the general formula (wherein R has the above definition) and the general formula (wherein X represents an atom atom, particularly a bromine atom). It can be obtained by reacting p-benzyloxy-α-halopropiophenone, which exists in
Generally, the reaction is carried out in a diluent in which the compound represented by the formula (I[) and the compound represented by the formula (I) are soluble, and the product of the general formula (2) is sparingly soluble or insoluble.

この希釈剤としては例えばアセトンもしくはメチルエチ
ルケトンの如く炭素数が3〜5の脂肪族飽和ケトンを用
いることができる。
As this diluent, for example, an aliphatic saturated ketone having 3 to 5 carbon atoms such as acetone or methyl ethyl ketone can be used.

あるいはまた、例えばメタノール、エタノールもしくは
イソプロパツールの如く低沸点の脂肪族飽和アルコール
より成る希釈剤を使用することもできる。
Alternatively, it is also possible to use diluents consisting of low-boiling aliphatic saturated alcohols, such as methanol, ethanol or isopropanol.

一般式代を有する生成物は、有機化学における通常の方
法により、反応混合物から単離することができる。
Products having the general formula can be isolated from the reaction mixture by conventional methods in organic chemistry.

したがって、生成した上記の生成物が反応混合物中で沈
澱となるならば、必要に応じ、反応混合物をあらかじめ
濃縮した後、沢過することによってその反応混合物から
単離することができる。
Therefore, if the above-mentioned product formed precipitates in the reaction mixture, it can be isolated from the reaction mixture by concentrating the reaction mixture in advance and then filtering it, if necessary.

次いで、式■で表わされるアンモニウム塩は、水素添加
触媒の存在下で水素添加することにより、一般式 (式中、Rは前述の定義を有する)で表わされる1−(
4−ヒドロキシ−フェニル)−2−ピペリジノ−1−プ
ロパツール誘導体に変換される。
The ammonium salt represented by the formula (2) is then hydrogenated in the presence of a hydrogenation catalyst to form a 1-(
4-hydroxy-phenyl)-2-piperidino-1-propatol derivative.

この水素添加触媒としては、元素周期律(フランス化学
会誌、1966年1月号の定義)の第■族の貴金属に基
づく触媒が好ましく使用される。
As this hydrogenation catalyst, a catalyst based on a noble metal of Group 1 of the Periodic Table of the Elements (defined in the Journal of the French Society of Chemistry, January 1966 issue) is preferably used.

この水素添加における処理条件は好ましくは次の通りで
ある。
The treatment conditions for this hydrogenation are preferably as follows.

触媒の量は式(5)の化合物に対し、1〜10重量%、
更に好ましくは2〜5%であり、水素添加温度は20°
〜100℃、好ましくは40°〜60℃である。
The amount of catalyst is 1 to 10% by weight based on the compound of formula (5),
More preferably, it is 2 to 5%, and the hydrogenation temperature is 20°
-100°C, preferably 40°-60°C.

この温度は、一般に比較的低温度の方が最終生成物の純
度に好影響を及ぼす。
Generally speaking, lower temperatures have a better effect on the purity of the final product.

水素圧力は5〜100 kg/crrtであるが、10
〜50 kg/crAの圧力で一般に充分である。
Hydrogen pressure is 5-100 kg/crrt, but 10
A pressure of ~50 kg/crA is generally sufficient.

上記の反応は、式(ト)の化合物のための溶媒例えば水
またはメタノール、エタノールもしくはイソプロパツー
ルの如き低沸点の脂肪族飽和アルコールの中で行なうの
が一般に好ましい。
It is generally preferred that the above reaction is carried out in a solvent for the compound of formula (g), such as water or a low boiling aliphatic saturated alcohol such as methanol, ethanol or isopropanol.

メタノールおよびエタノールは、最終生成物がこれら溶
媒に可溶であるために、特に好適であり、反応操作の終
了時に沢過することによって、反応混合物から触媒を容
易に除くことができる。
Methanol and ethanol are particularly suitable, since the final products are soluble in these solvents, and the catalyst can be easily removed from the reaction mixture by filtration at the end of the reaction operation.

この水素添加は、一般式(5)の化合物の製造時に製造
が行われたその場で、即ち式([[)の化合物と式(ホ
)の化合物との反応によって生ずる反応混合物中におい
て、生成した式■の生成物を予め単離することなく、直
接に行なうこともできる。
This hydrogenation is carried out on the spot where the compound of general formula (5) is produced, that is, in the reaction mixture produced by the reaction of the compound of formula ([[) and the compound of formula (e)]. It can also be carried out directly, without prior isolation of the product of formula (2).

この水素添加によって得られた生成物は有機化学におけ
る通常の方法、例えば冷却による沈澱生成、それに続く
沢過などの方法によって(必要な場合には反応混合物を
減圧下で濃縮することも好ましい方法である)単離する
ことができる。
The products obtained by this hydrogenation can be prepared by conventional methods in organic chemistry, such as precipitation by cooling followed by filtration (if necessary, concentration of the reaction mixture under reduced pressure is also preferred). ) can be isolated.

この様にして得られた式(I)を有する生成物のヒドロ
ハライドは対応する塩基に変えることができるが、この
変換法はそれ自体既知の方法であってよく、付加塩を対
応する有機塩基にすることのできる如何なる方法であっ
てもよい。
The hydrohalide of the product having the formula (I) obtained in this way can be converted into the corresponding base, but this conversion method may be a method known per se, and the addition salt can be converted into the corresponding organic base. Any method that can be used may be used.

例えば、上記のヒドロハライドは、水または例えばメタ
ノールもしくはエタノールの如き脂肪族飽和アルコール
の様な溶媒中で、少なくとも化学量論量のアルカリ塩基
例えばアンモニアを用いて処理することができる。
For example, the hydrohalides described above can be treated with at least a stoichiometric amount of an alkali base such as ammonia in a solvent such as water or an aliphatic saturated alcohol such as methanol or ethanol.

かくして得られた塩基は、次に好適な溶媒中で、酸と反
応させることにより、無機酸例えばハロゲン化水素酸殊
に臭化水素酸または有機酸例えば酒石酸との付加塩に変
えることができる。
The base thus obtained can then be converted into an addition salt with an inorganic acid, such as a hydrohalic acid, especially hydrobromic acid, or an organic acid, such as tartaric acid, by reaction with an acid in a suitable solvent.

その際の溶媒としては例えば、アルコール、ケトン、エ
ーテルまたは塩素化された溶剤が溶媒として使用される
The solvent used in this case is, for example, alcohol, ketone, ether or chlorinated solvent.

生成した塩は沈澱するが、必要な場合はその溶液を濃縮
した後、戸別する。
The salt produced will precipitate, and if necessary, the solution will be concentrated and then distributed.

次に、実施例を掲げ、本発明を説明する。Next, the present invention will be described with reference to Examples.

実施例 1 (a)4−メチル−ピリジン(20′fI)、p−ベン
ジルオキシ−α−プロモープロピオフェノン(68,6
f)およびメチルエチルケトン(200ml)の混合物
を、還流および攪拌の下で4時間加熱する。
Example 1 (a) 4-methyl-pyridine (20'fI), p-benzyloxy-α-promopropiophenone (68,6
A mixture of f) and methyl ethyl ketone (200 ml) is heated under reflux and stirring for 4 hours.

得られた溶媒を約O℃まで徐冷する。The resulting solvent is slowly cooled to about 0°C.

生じた沈澱を戸別し、メチルエチルケトン(50TLl
)で洗浄し、次いで50℃で減圧乾燥する。
The resulting precipitate was collected door to door, and methyl ethyl ketone (50 TLl
) and then dried under reduced pressure at 50°C.

かくして、l−41−(4−ベンジルオキシフェニル−
カルボニル)−エチルクー4−メチル−ピリジニウム・
プロミド (79,]J)が得られる。
Thus, l-41-(4-benzyloxyphenyl-
carbonyl)-ethylcou 4-methyl-pyridinium
Promide (79,]J) is obtained.

(b) 1−(1−(4−ベンジルオキシフェニル−
カルボニル)−エチルロー4−メチルーヒリシニウム・
プロミド(20f)、無水メタノール(20QmA)お
よび活性炭上に沈着させたパラジウム(パラジウム含量
、10%)より成る水素添加触媒(2,S?)を500
rfLlのオートクレーブに入れる。
(b) 1-(1-(4-benzyloxyphenyl-
carbonyl)-ethylrho-4-methylhyricinium
A hydrogenation catalyst (2,S?) consisting of bromide (20f), anhydrous methanol (20QmA) and palladium (palladium content, 10%) deposited on activated carbon was
Place in rfLl autoclave.

そのオートクレーブを窒素を用いて置換し、次いで水素
圧を25kg/c4にする。
The autoclave is purged with nitrogen and then the hydrogen pressure is brought to 25 kg/c4.

オートクレーブを攪拌し、そして水素圧(25に’/c
trl )の下で50〜55℃に24時間保つ。
Stir the autoclave and increase the hydrogen pressure (25'/c
trl) at 50-55°C for 24 hours.

オートクレーブを、窒素を用いて置換した後、触媒を沢
過によって反応混合物から除き、次いで熱メタノール(
60QrfLl)を用いて洗浄する。
After purging the autoclave with nitrogen, the catalyst was removed from the reaction mixture by filtration and then heated with methanol (
60QrfLl).

p液を合併し、そして減圧下で濃縮乾固する。Combine the p-solutions and concentrate to dryness under reduced pressure.

得られた残留物を水(’4orILl)に入れる。The resulting residue is taken up in water ('4orILl).

結晶を戸別I〜、水で洗浄した後、50℃で減圧下に乾
燥する。
The crystals are washed individually with water and then dried under reduced pressure at 50°C.

かくして、1−(4−ヒドロキシ−フェニル)−2−(
4−メチル−ピペリジノ)−1−プロパツール・ヒドロ
プロミド(1of)が白色粉末として得られる。
Thus, 1-(4-hydroxy-phenyl)-2-(
4-Methyl-piperidino)-1-propatur hydropromide (1of) is obtained as a white powder.

実施例 2 (a)4−エチル−ピリジン(24,:l)、p−ベン
ジルオキシ−α−プロモープロピオフェノン(72,5
?)およびメチルエチルケトン(250wLl)の混合
物を還流および攪拌の下で4時間加熱する。
Example 2 (a) 4-ethyl-pyridine (24,:l), p-benzyloxy-α-promopropiophenone (72,5
? ) and methyl ethyl ketone (250 wLl) is heated under reflux and stirring for 4 hours.

その反応混合物を、容量が80rnlになるまで、減圧
濃縮する。
The reaction mixture is concentrated under reduced pressure to a volume of 80 rnl.

冷却すると沈澱が生ずるが、その混合物を0℃で2時間
保った後、戸別する。
Upon cooling, a precipitate forms, and the mixture is kept at 0° C. for 2 hours and then separated.

その沈澱をヘキサンで洗浄し、50℃で減圧乾燥すると
、1−(1−(4−ベンジルオキシフェニル−カルボニ
ル)−エチルロー4−エチル−ピリジニウム・プロミド
(74,29)が得られる。
The precipitate is washed with hexane and dried under reduced pressure at 50°C to obtain 1-(1-(4-benzyloxyphenyl-carbonyl)-ethylrho-4-ethyl-pyridinium bromide (74,29).

(b) 1−(1−(4−ベンジルオキシフェニル−
カルボニル)−エチル〕−4−エチルーヒリジニウム・
プロミド(20?)、無水メタノール(200ml)お
よび活性炭上に沈着させたパラジウム(パラジウム含量
、5%)より成り、かつ比表面積が1000 rn”/
’ifの水素添加触媒(47)を500m1のオートク
レーブに入れる。
(b) 1-(1-(4-benzyloxyphenyl-
carbonyl)-ethyl]-4-ethylhyridinium
bromid (20?), anhydrous methanol (200 ml) and palladium (palladium content, 5%) deposited on activated carbon and with a specific surface area of 1000 rn”/
'if hydrogenation catalyst (47) is placed in a 500ml autoclave.

そのオートクレーブ内を窒素で置換し、次いで水素圧を
25 kg/c4にする。
The inside of the autoclave is purged with nitrogen, and then the hydrogen pressure is set to 25 kg/c4.

オートクレーブを攪拌し、そして水素圧(25kg/c
rri )の下で50〜55℃に70時間保つ。
The autoclave was stirred and hydrogen pressure (25 kg/c
rri) at 50-55°C for 70 hours.

オートクレーブ内を窒素で置換した後、触媒を沢過によ
って反応混合物から除き、熱メタノールで2回(全容量
、80rILl)、洗浄する。
After purging the autoclave with nitrogen, the catalyst is removed from the reaction mixture by filtration and washed twice with hot methanol (total volume, 80 rILl).

P液を合併し、そして最終容量が35m1になるまで、
45℃以下で減圧濃縮する。
Combine the P solution and until the final volume is 35ml.
Concentrate under reduced pressure below 45°C.

残留物は、沈澱が生じた後、0℃で1時間冷却し、そし
て沈澱を戸別し、50℃で減圧乾燥する。
After precipitation, the residue is cooled at 0°C for 1 hour, and the precipitate is separated and dried under reduced pressure at 50°C.

かくして、1−(4−ヒドロキシ−フェニル)−2−(
4−エチル−ピペリジン)−プロパツール・ヒドロプロ
ミド(10,El)が白色粉末として得られる。
Thus, 1-(4-hydroxy-phenyl)-2-(
4-ethyl-piperidine)-propatur hydropromide (10, El) is obtained as a white powder.

実施例 3 (a)4−ベンジル−ピリジン(60,7P)、p−ペ
ンジルオキシーα−プロモープロピオフェノン(114
,6f)およびアセトン(250rILl)の混合物を
還流および攪拌の下で2時間加熱する。
Example 3 (a) 4-benzyl-pyridine (60,7P), p-penzyloxy-α-promopropiophenone (114
, 6f) and acetone (250 rILl) is heated under reflux and stirring for 2 hours.

20℃に冷却後、生じた沈澱を戸別する。得られた生成
物をアセトン(100rnl)中に入れ、一時間還流さ
せ、次いで戸別した後、50℃で減圧乾燥する。
After cooling to 20°C, the resulting precipitate is separated. The resulting product is placed in acetone (100 rnl), refluxed for 1 hour, then taken apart and dried under reduced pressure at 50°C.

かくして、1−(1−(4−ベンジルオキシフェニル−
カルボニル)−エチルシー4−ベンジル−ピリジニウム
・プロミド(x6x’7)が得られる。
Thus, 1-(1-(4-benzyloxyphenyl-
Carbonyl)-ethylcy4-benzyl-pyridinium bromide (x6x'7) is obtained.

(b) 1−(1−(4−ベンジルオキシフェニル−
カルボニル)−エチルシー4−ベンジル−ピリジニウム
・プロミド(20f)、無水メタノール(200rIL
l)および活性炭上に沈着させたパラジウム(パラジウ
ム含量、10%)より成る水素添加触媒(2,5P)を
500rILlのオートクレーブに入れる。
(b) 1-(1-(4-benzyloxyphenyl-
carbonyl)-ethylcy4-benzyl-pyridinium bromide (20f), anhydrous methanol (200rIL
1) and a hydrogenation catalyst (2,5P) consisting of palladium (palladium content, 10%) deposited on activated carbon are placed in a 500 rILl autoclave.

そのオートクレーブ内を窒素で置換し、次いで水素圧を
25 kg/caにする。
The inside of the autoclave was purged with nitrogen, and then the hydrogen pressure was set to 25 kg/ca.

オートクレーブを攪拌し、そして水素圧(25kg/c
a)の下で50〜55℃に23時間保つ。
The autoclave was stirred and hydrogen pressure (25 kg/c
Keep under a) at 50-55°C for 23 hours.

オートクレーブ内を窒素で置換した後、触媒を沢過によ
って反応混合物から除き、次いで熱メタノール(600
7711)で洗浄する。
After purging the inside of the autoclave with nitrogen, the catalyst was removed from the reaction mixture by filtration, and then hot methanol (600
7711).

f液を合併し、そして黄褐色の残留物が得られるまで減
圧濃縮する。
Combine the f liquids and concentrate under reduced pressure until a tan residue is obtained.

この残留物を無水エタノール(50ml)に溶解し、5
0℃で一時間保つ。
This residue was dissolved in absolute ethanol (50 ml) and
Keep at 0℃ for 1 hour.

冷却後、結晶をP別し、そして50℃で減圧乾燥する。After cooling, the crystals are separated from P and dried under reduced pressure at 50°C.

かくして、1−(4−ヒドロキシ−フェニル)−2−(
4−ベンジル−ピペリジノ)−1−7’ロバノール・ヒ
ドロプロミド(12f)が得られる。
Thus, 1-(4-hydroxy-phenyl)-2-(
4-Benzyl-piperidino)-1-7' lovanol hydropromide (12f) is obtained.

薄層クロマトグラフィー(支持体、珪藻土:溶剤、クロ
ロホルム−ジエチルアミン、容量比95−5)は、紫外
光の検査により、単一生成物の存在を示す(Rf#0.
35)。
Thin layer chromatography (support, diatomaceous earth:solvent, chloroform-diethylamine, volume ratio 95-5) shows the presence of a single product (Rf#0.
35).

実施例 4 (a)4−ベンジル−ピリジン(42,5P)、p−ベ
ンジルオキシ−α−プロモープロピオフェノン(79,
7s’)および無水メタノール(240rnl)の混合
物を還流および攪拌の下で8時間加熱する。
Example 4 (a) 4-benzyl-pyridine (42,5P), p-benzyloxy-α-promopropiophenone (79,
A mixture of 7s') and anhydrous methanol (240 rnl) is heated under reflux and stirring for 8 hours.

得られた溶液を直接に1−(4−ヒドロキシ−フェニル
)−2−(4−ベンジル−ピペリジノ)−1−プロパツ
ールの製造用に使用する。
The solution obtained is used directly for the preparation of 1-(4-hydroxy-phenyl)-2-(4-benzyl-piperidino)-1-propatol.

(b) 上記の溶滴、無水メタノール(840r/′
Ll)および活性炭上に沈着させたパラジウム(パラジ
ウム含量、10%)より成る水素添加触媒(6グ)を3
1のオートクレーブに入れる。
(b) The above droplets, anhydrous methanol (840 r/'
Ll) and a hydrogenation catalyst (6 g) consisting of palladium (palladium content, 10%) deposited on activated carbon.
Place in autoclave 1.

そのオートクレーブ内を窒素で置換し、次いで水素圧を
25 kg/crAにする。
The inside of the autoclave is purged with nitrogen, and then the hydrogen pressure is set to 25 kg/crA.

オートクレーブを攪拌し、そして水素圧(25kg/c
rA )の下で50〜55℃に24時間保つ。
The autoclave was stirred and hydrogen pressure (25 kg/c
Keep at 50-55 °C under rA) for 24 hours.

オートクレーブ内を窒素で置換した後、触媒を沢過によ
って反応混合物から除き、次いで熱メタノール(100
ml)で洗浄する。
After purging the autoclave with nitrogen, the catalyst was removed from the reaction mixture by filtration, and then heated with methanol (100
ml).

涙液を合併し、そして沈澱が生ずるまでメタノールを6
段カラムにより35〜40℃で減圧下に留去する。
Combine the lachrymal fluid and add methanol until a precipitate forms.
Distill under reduced pressure at 35-40° C. through a plate column.

次いで、その残留物に水(410rILl)を加えた後
、上記と同様に、カラムの頂部で30〜35℃を超える
ことなく、メタノールを再び除去する。
Then, after adding water (410 rILl) to the residue, the methanol is removed again as above, without exceeding 30-35° C. at the top of the column.

メタノールを除去した後、残留物に水(200rfLl
)を加える。
After removing the methanol, the residue was soaked with water (200 rfLl
) is added.

かくして、■−(4−ヒドロキシ−フェニル)−2−(
4−ベンジル−ピペリジノ)−1−プロパツール・ヒド
ロプロミドの懸濁物が得られる。
Thus, ■-(4-hydroxy-phenyl)-2-(
A suspension of 4-benzyl-piperidino)-1-propatur hydropromide is obtained.

ジクロロエタン(1600ml)と濃アンモニア(d=
0.92 ) (35m1)とをコノ懸濁物に加え、そ
してその混合物を70℃に1時間加熱する。
Dichloroethane (1600ml) and concentrated ammonia (d=
0.92 ) (35 ml) is added to the cono suspension and the mixture is heated to 70° C. for 1 hour.

熱いうちに有機相を傾しゃ分離し、次いで、70℃の水
で4回(全容量1600rI′Ll)洗浄する。
The organic phase is decanted while hot and then washed four times with water at 70° C. (total volume 1600 rI'Ll).

約20℃に冷却すると沈澱が現われるが、その混合物を
0℃に1時間冷却した後、生じた沈澱を戸別する。
A precipitate appears on cooling to about 20°C, and after cooling the mixture to 0°C for 1 hour, the resulting precipitate is separated.

ヘキサン(300ml)で洗浄し、50℃で減圧乾燥す
ると、1−(4−ヒドロキシ−フェニル)−2−(4−
ベンジル−ピペリジノ)−1−プロパツール(71ti
?)が白色粉末として得られる。
After washing with hexane (300 ml) and drying under reduced pressure at 50°C, 1-(4-hydroxy-phenyl)-2-(4-
benzyl-piperidino)-1-propertool (71ti
? ) is obtained as a white powder.

薄層クロマトグラフィー(支持体、珪藻土;溶剤、クロ
ロホルム−ジエチルアミン、容量比95−5)は、紫外
光の検査によj?、単一生成物・の存在を示す(Rf#
0.35 )。
Thin layer chromatography (support, diatomaceous earth; solvent, chloroform-diethylamine, volume ratio 95-5) was performed by ultraviolet light examination. , indicating the presence of a single product (Rf#
0.35).

実施例 5 ■−(4−ヒドロキシ−フェニル)−2−(4−ペンジ
ル−ピペリジノ)−1−プロパツール(31’)(実施
例4の記載と同様にして得られたもの)を50〜55°
Cの無水メタノール(90ml)に溶解する。
Example 5 ■-(4-Hydroxy-phenyl)-2-(4-penzyl-piperidino)-1-propatool (31') (obtained as described in Example 4) at 50 to 55 °
Dissolve C in anhydrous methanol (90 ml).

酒石酸(6,94?)の無水メタノール(39ml)溶
液を50〜55℃で攪拌下に上記の溶液へ加え、その反
応混合物を50〜55℃に15分間保つ。
A solution of tartaric acid (6,94?) in anhydrous methanol (39 ml) is added to the above solution under stirring at 50-55°C and the reaction mixture is kept at 50-55°C for 15 minutes.

その後、約20℃に冷却し、次いで0℃に2時間保つ。It is then cooled to about 20°C and then kept at 0°C for 2 hours.

沈澱を戸別し、メタノール(30ml)で洗浄の後、5
0℃で減圧乾燥する。
After washing the precipitate with methanol (30 ml),
Dry under reduced pressure at 0°C.

かくして、1−(4−ヒドロキシ−フェニル)−2−(
4−ベンジル−ピペリジノ)−1−プロパツール・酒石
酸塩(32,6f)白色粉末として得られる。
Thus, 1-(4-hydroxy-phenyl)-2-(
4-Benzyl-piperidino)-1-propatol tartrate (32,6f) Obtained as a white powder.

薄層クロマトグラフィー(支持体、珪藻土;溶剤、クロ
ロホルム−ジエチルアミン、容量比95−5)は、紫外
光の検査により、単一生成物の存在を示す(Rf#0.
35)。
Thin layer chromatography (support, diatomaceous earth; solvent, chloroform-diethylamine, volume ratio 95-5) shows the presence of a single product (Rf#0.
35).

実施例 6 (a)4−フェニル−ピリジン(2Of)、p−ベンジ
ルオキシ−α−プロモープロピオフェノン(41,2f
)およびメチルエチルケトン(200ml)の混合物を
還流および攪拌の下で4時間加熱する。
Example 6 (a) 4-phenyl-pyridine (2Of), p-benzyloxy-α-promopropiophenone (41,2f)
) and methyl ethyl ketone (200 ml) is heated under reflux and stirring for 4 hours.

得られた溶液を約20℃に冷却し、次いで0℃に1時間
保つ。
The resulting solution is cooled to about 20°C and then kept at 0°C for 1 hour.

生じた沈澱を戸別し、冷メチルエチルケトン(50m1
)で洗浄し、次いで50℃で減圧乾燥する。
The resulting precipitate was taken from house to house and poured into cold methyl ethyl ketone (50ml
) and then dried under reduced pressure at 50°C.

かくして、1−〔1−(4−ベンジルオキシフェニル−
カルボニル)−エチルター4−フエニルーヒリジニウム
・プロミド(57?)が得られる。
Thus, 1-[1-(4-benzyloxyphenyl-
Carbonyl)-ethylter-4-phenylhyridinium bromide (57?) is obtained.

(b) 1−(1−(4−ベンジルオキシフェニル−
カルボニル)−エチルター4−フエニルーヒリジニウム
・プロミド(14,71?)、メタノール(200rI
Ll)および活性炭上に沈着させたパラジウム(パラジ
ウム含量、5%)より成り、かつ比表面積が1000m
”/Pの水素添加触媒(42)を500m1のオートク
レーブに入れる。
(b) 1-(1-(4-benzyloxyphenyl-
carbonyl)-ethylter-4-phenylhyridinium bromide (14,71?), methanol (200 rI
Ll) and palladium (palladium content, 5%) deposited on activated carbon and with a specific surface area of 1000 m
”/P hydrogenation catalyst (42) is placed in a 500 ml autoclave.

そのオートクレーブを窒素で置換し、次いで水素圧を2
5kg/crAにする。
The autoclave was purged with nitrogen and the hydrogen pressure was increased to 2
Set it to 5kg/crA.

オートクレーブを攪拌し、そして水素圧(25kg/c
m )の下で50〜55℃に24時間保つ。
The autoclave was stirred and hydrogen pressure (25 kg/c
m) at 50-55 °C for 24 hours.

オートクレーブを窒素で置換した後、触媒を沢過によっ
て反応混合物から除き、次いで熱メタノールで2回(全
容量80rrLl)洗浄する。
After purging the autoclave with nitrogen, the catalyst is removed from the reaction mixture by filtration and then washed twice with hot methanol (total volume 80 rrLl).

f液を合併し、そして容量が50m1になるまでメタノ
ールを、45℃を超えることなく、減圧下で留去する。
The f liquids are combined and the methanol is distilled off under reduced pressure without exceeding 45° C. until the volume is 50 ml.

約20°Cに冷却し、次いで0℃に3時間保った後、生
じた沈澱をr別し、ヘキサン(60ml)で洗浄し、次
いで50℃で減圧乾燥する。
After cooling to about 20°C and then keeping at 0°C for 3 hours, the resulting precipitate is separated, washed with hexane (60ml) and then dried under reduced pressure at 50°C.

かくして、1−(4−ヒドロキシ−フェニル)−2−(
4−フェニル−ピペリジノ)−1−7”ロバノール・ヒ
ドロプロミド(9,3S’)が白色粉末として得られる
Thus, 1-(4-hydroxy-phenyl)-2-(
4-phenyl-piperidino)-1-7'' lovanol hydropromide (9,3S') is obtained as a white powder.

Claims (1)

【特許請求の範囲】 1 一般式 (式中、Rはアルキル基、アリールアルキル基またはア
リール基を示し、Xeはハロゲンイオンヲ示す)を有す
るアンモニウム塩を水素添加触媒の存在下で水素添加す
ることを特徴とする一般式(式中、Rは前記の定義を有
する)で表わされるピペリジノーグロパノール誘導体お
よびその酸付加塩の製造法。 2 一般式 (式中、Rはアルキル基、アリールアルキル基またはア
リール基を示す)を有する置換ピリジンと一般式 (式中、Xはハロゲン原子を示す)を有するp−ベンジ
ルオキシ−α−ハロープロピオフェノンとを反応せしめ
て一般式、 (式中、Rは前述の定義を有し、そしてX○はハロゲン
イオンを示す)を有するアンモニウム塩を製造し、次い
でこれを水素添加触媒の存在下で水素添加することを特
徴とする式 (式中、Rは前述の定義を有する)で表わされるピペリ
ジノーグロパノール誘導体およびその酸付加塩の製造法
[Claims] 1. Hydrogenating an ammonium salt having the general formula (wherein R represents an alkyl group, an arylalkyl group, or an aryl group, and Xe represents a halogen ion) in the presence of a hydrogenation catalyst. A method for producing a piperidinoglopanol derivative represented by the general formula (wherein R has the above definition) and an acid addition salt thereof, characterized by: 2 Substituted pyridine having the general formula (in the formula, R represents an alkyl group, arylalkyl group or aryl group) and p-benzyloxy-α-halopropylene having the general formula (in the formula, X represents a halogen atom) An ammonium salt having the general formula: where R has the above definition and X represents a halogen ion is prepared by reacting with piophenone, which is then reacted in the presence of a hydrogenation catalyst A method for producing a piperidinoglopanol derivative represented by the formula (wherein R has the above definition) and an acid addition salt thereof, which is characterized by hydrogenation.
JP21590781A 1972-12-04 1981-12-28 Method for producing piperidino-propanol derivatives Expired JPS5824434B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7243053A FR2208901A1 (en) 1972-12-04 1972-12-04 Alpha-(4-substd pyridino)-4-benzyloxypropiophenones - as inters for cardiovascular 1-(4-hydroxy-phenyl)-2-(4-substd piperidino) propan-1-ols

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP13365673A Division JPS5824435B2 (en) 1972-12-04 1973-11-30 Die 4 Ammonium Enno Seizouhouhou

Publications (2)

Publication Number Publication Date
JPS57188569A JPS57188569A (en) 1982-11-19
JPS5824434B2 true JPS5824434B2 (en) 1983-05-20

Family

ID=9108152

Family Applications (2)

Application Number Title Priority Date Filing Date
JP13365673A Expired JPS5824435B2 (en) 1972-12-04 1973-11-30 Die 4 Ammonium Enno Seizouhouhou
JP21590781A Expired JPS5824434B2 (en) 1972-12-04 1981-12-28 Method for producing piperidino-propanol derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP13365673A Expired JPS5824435B2 (en) 1972-12-04 1973-11-30 Die 4 Ammonium Enno Seizouhouhou

Country Status (2)

Country Link
JP (2) JPS5824435B2 (en)
FR (1) FR2208901A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS547205A (en) * 1977-06-20 1979-01-19 Nippon Telegr & Teleph Corp <Ntt> Privacy circuit
JPS6034951B2 (en) * 1979-09-13 1985-08-12 東洋フアルマ−株式会社 Method for producing 1-(4-hydroxyphenyl)-2-(4-benzylpiperidino)propan-1-ol
GB2067187B (en) * 1979-12-07 1983-11-30 Cosmos Enterprise Process for the preparation of 1-(4-hydroxyphenyl)-2-(4-benzylpiperidino)-1-propanol and acid addition salts thereof
FR2534580A1 (en) * 1982-10-13 1984-04-20 Synthelabo PHENYL-1 PIPERIDINO-2 PROPANOL DERIVATIVES, THEIR PREPARATION, AND MEDICINES THAT CONTAIN THEM
DE19647413A1 (en) * 1996-11-15 1998-05-20 Hoechst Schering Agrevo Gmbh Substituted nitrogen heterocycles, processes for their preparation and their use as pesticides

Also Published As

Publication number Publication date
JPS57188569A (en) 1982-11-19
JPS504081A (en) 1975-01-16
JPS5824435B2 (en) 1983-05-20
FR2208901B1 (en) 1976-08-20
FR2208901A1 (en) 1974-06-28

Similar Documents

Publication Publication Date Title
Micovic et al. The reduction of acid amides with lithium aluminum hydride
TWI345562B (en) Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
EP0566468B1 (en) Process for the preparation of a biphenyl derivative
JPS5943459B2 (en) N-alkylpiperidine derivative
DK158980B (en) METHOD OF ANALOGUE FOR PREPARATION OF 2,5-BIS- (2,2,2-TRIFLUORETHOXY) -N- (2-PIPERIDYLMETHYL) BENZAMIDE OR A PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALT
EP1861389B1 (en) 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof
BRPI1010300B1 (en) processes for the preparation of a compound, dronedarone, or a salt thereof, a pharmaceutical formulation, and a dronedarone intermediate, or a salt thereof
JPS5824434B2 (en) Method for producing piperidino-propanol derivatives
Robison The Preparation of 1, 5-Pyrindine1
US4191828A (en) Process for preparing 2-(2,2-dicyclohexylethyl)piperidine
SU535899A3 (en) The method of obtaining - (1-bisarylalkylaminoalkyl) -aralkoxybenzyl alcohols or their salts, racemates or optically active antipodes
Correia Reaction of phenylglyoxal with aniline under acidic conditions
FI85465B (en) FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA 4-FENYLPROPYL-INDOLDERIVAT.
FR2560873A1 (en) PIPERIDINE DERIVATIVE MEDICINES, NOVEL PIPERIDINE DERIVATIVES AND METHODS FOR PREPARING THE SAME
Holcomb et al. Derivatives of 4-amino-6-methoxyquinaldine
Hayes et al. Some Furan Antihistaminic Agents
EP2639212B1 (en) Enantioselective organic anhydride reactions
BE1000112A5 (en) METHOD FOR PREPARING encainide.
KR960007523B1 (en) 4-arylcarbonyl-1-£(4-morpholinyl)-lower-alkyl|-1h-indoles
Buck et al. Some Chlorinated 4-Indanols: Preparation and Proof of Structures1
FR2685698A1 (en) BENZOFURANYLIMIDAZOLE DERIVATIVES AND METHOD FOR THE PREPARATION THEREOF.
US4229375A (en) 1-Aminomethyltricyclo[4.3.1.12,5 ]undecane and acid-addition salts thereof
JP2762106B2 (en) Method for producing 3-hydroxypyrrolidine
FR2738567A1 (en) ALPHA-PHENYLPIPERIDINE-1-PROPANOL DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
JP2880203B2 (en) Preparation of furanone derivatives